eXoZymes, Inc. (EXOZ)

eXoZymes Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023
Selling, General & Admin	5.36	4.06	1.34
Research & Development	2.73	1.87	0.53
Total Operating Expenses	8.09	5.93	1.87
Operating Income	-8.09	-5.93	-1.8
Interest Income	0.28	0.08	0
Other Non-Operating Income (Expense)	-	-0.01	0.2
Total Non-Operating Income (Expense)	0.28	0.07	0.2
Pretax Income	-7.71	-5.86	-2
Provision for Income Taxes	0	-	0.04
Net Income	-7.71	-5.86	-2.04
Net Income to Common	-7.71	-5.86	-2.04
Shares Outstanding (Basic)	-	7	6
Shares Outstanding (Diluted)	-	7	6
Shares Change (YoY)	-	5.01%	-
EPS (Basic)	-	-0.89	-0.33
EPS (Diluted)	-	-0.89	-0.33
Free Cash Flow	-8.92	-8.9	-1.47
Free Cash Flow Per Share	-	-1.36	-0.24
EBITDA	-7.84	-5.68	-1.64
EBIT	-8.09	-5.93	-1.8
Effective Tax Rate	-0.03%	0.00%	-2.12%

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q